Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 12 |
GO:0042995 | cell projection | 2 | 12 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 12 |
Related structures:
AlphaFold database: E9AI71
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005509 | calcium ion binding | 5 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 212 | 216 | PF00656 | 0.409 |
CLV_C14_Caspase3-7 | 52 | 56 | PF00656 | 0.271 |
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.307 |
CLV_NRD_NRD_1 | 83 | 85 | PF00675 | 0.286 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 83 | 85 | PF00082 | 0.284 |
CLV_PCSK_PC1ET2_1 | 181 | 183 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.349 |
CLV_PCSK_SKI1_1 | 276 | 280 | PF00082 | 0.341 |
CLV_Separin_Metazoa | 220 | 224 | PF03568 | 0.484 |
DEG_APCC_DBOX_1 | 36 | 44 | PF00400 | 0.278 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.522 |
DEG_SCF_FBW7_1 | 38 | 45 | PF00400 | 0.501 |
DOC_CKS1_1 | 359 | 364 | PF01111 | 0.526 |
DOC_CYCLIN_yCln2_LP_2 | 363 | 369 | PF00134 | 0.598 |
DOC_MAPK_DCC_7 | 181 | 191 | PF00069 | 0.282 |
DOC_MAPK_gen_1 | 83 | 93 | PF00069 | 0.337 |
DOC_MAPK_HePTP_8 | 138 | 150 | PF00069 | 0.388 |
DOC_MAPK_MEF2A_6 | 141 | 150 | PF00069 | 0.390 |
DOC_USP7_MATH_1 | 42 | 46 | PF00917 | 0.434 |
DOC_USP7_UBL2_3 | 237 | 241 | PF12436 | 0.579 |
DOC_WW_Pin1_4 | 244 | 249 | PF00397 | 0.535 |
DOC_WW_Pin1_4 | 358 | 363 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.370 |
LIG_14-3-3_CanoR_1 | 151 | 156 | PF00244 | 0.292 |
LIG_14-3-3_CanoR_1 | 325 | 335 | PF00244 | 0.431 |
LIG_14-3-3_CanoR_1 | 87 | 92 | PF00244 | 0.485 |
LIG_Actin_WH2_2 | 23 | 41 | PF00022 | 0.299 |
LIG_APCC_ABBA_1 | 231 | 236 | PF00400 | 0.457 |
LIG_BRCT_BRCA1_1 | 89 | 93 | PF00533 | 0.451 |
LIG_Clathr_ClatBox_1 | 259 | 263 | PF01394 | 0.473 |
LIG_EH1_1 | 255 | 263 | PF00400 | 0.458 |
LIG_FHA_1 | 226 | 232 | PF00498 | 0.468 |
LIG_FHA_2 | 264 | 270 | PF00498 | 0.439 |
LIG_FHA_2 | 31 | 37 | PF00498 | 0.435 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.428 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.337 |
LIG_LIR_Gen_1 | 215 | 224 | PF02991 | 0.412 |
LIG_LIR_Gen_1 | 236 | 246 | PF02991 | 0.409 |
LIG_LIR_Gen_1 | 254 | 262 | PF02991 | 0.211 |
LIG_LIR_Gen_1 | 29 | 38 | PF02991 | 0.348 |
LIG_LIR_Gen_1 | 334 | 345 | PF02991 | 0.310 |
LIG_LIR_Gen_1 | 55 | 65 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 215 | 221 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 236 | 242 | PF02991 | 0.400 |
LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.207 |
LIG_LIR_Nem_3 | 29 | 34 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 334 | 340 | PF02991 | 0.298 |
LIG_LIR_Nem_3 | 55 | 60 | PF02991 | 0.494 |
LIG_NRBOX | 256 | 262 | PF00104 | 0.466 |
LIG_SH2_CRK | 31 | 35 | PF00017 | 0.404 |
LIG_SH2_PTP2 | 147 | 150 | PF00017 | 0.378 |
LIG_SH2_STAP1 | 267 | 271 | PF00017 | 0.292 |
LIG_SH2_STAT3 | 105 | 108 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.336 |
LIG_SH2_STAT5 | 126 | 129 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.396 |
LIG_SH2_STAT5 | 238 | 241 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 296 | 299 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 342 | 345 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.330 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.355 |
LIG_SH3_1 | 182 | 188 | PF00018 | 0.444 |
LIG_SH3_3 | 182 | 188 | PF00018 | 0.521 |
LIG_SH3_3 | 283 | 289 | PF00018 | 0.437 |
LIG_SH3_3 | 343 | 349 | PF00018 | 0.528 |
LIG_SH3_3 | 45 | 51 | PF00018 | 0.403 |
LIG_SUMO_SIM_anti_2 | 44 | 50 | PF11976 | 0.252 |
LIG_SUMO_SIM_par_1 | 257 | 263 | PF11976 | 0.446 |
LIG_TRAF2_1 | 336 | 339 | PF00917 | 0.219 |
LIG_TYR_ITIM | 145 | 150 | PF00017 | 0.376 |
MOD_CK1_1 | 153 | 159 | PF00069 | 0.424 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.467 |
MOD_CK1_1 | 247 | 253 | PF00069 | 0.461 |
MOD_CK1_1 | 312 | 318 | PF00069 | 0.561 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.460 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.376 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.440 |
MOD_CK2_1 | 23 | 29 | PF00069 | 0.339 |
MOD_CK2_1 | 263 | 269 | PF00069 | 0.526 |
MOD_CK2_1 | 333 | 339 | PF00069 | 0.454 |
MOD_GlcNHglycan | 120 | 124 | PF01048 | 0.455 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.393 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.530 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.415 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.350 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.318 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.410 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.444 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.513 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.512 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.428 |
MOD_N-GLC_1 | 99 | 104 | PF02516 | 0.325 |
MOD_NEK2_1 | 150 | 155 | PF00069 | 0.404 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.478 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.509 |
MOD_NEK2_1 | 309 | 314 | PF00069 | 0.414 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.355 |
MOD_PIKK_1 | 69 | 75 | PF00454 | 0.461 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.393 |
MOD_PKA_2 | 222 | 228 | PF00069 | 0.515 |
MOD_PKA_2 | 312 | 318 | PF00069 | 0.545 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.550 |
MOD_Plk_1 | 330 | 336 | PF00069 | 0.301 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.327 |
MOD_Plk_2-3 | 263 | 269 | PF00069 | 0.442 |
MOD_Plk_4 | 209 | 215 | PF00069 | 0.412 |
MOD_Plk_4 | 267 | 273 | PF00069 | 0.381 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.232 |
MOD_ProDKin_1 | 244 | 250 | PF00069 | 0.533 |
MOD_ProDKin_1 | 358 | 364 | PF00069 | 0.500 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.374 |
MOD_SUMO_rev_2 | 173 | 183 | PF00179 | 0.341 |
TRG_DiLeu_BaEn_4 | 2 | 8 | PF01217 | 0.386 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.378 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.282 |
TRG_ER_diArg_1 | 37 | 40 | PF00400 | 0.424 |
TRG_ER_diArg_1 | 83 | 85 | PF00400 | 0.286 |
TRG_NES_CRM1_1 | 269 | 285 | PF08389 | 0.277 |
TRG_Pf-PMV_PEXEL_1 | 194 | 199 | PF00026 | 0.391 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDI3 | Leptomonas seymouri | 60% | 93% |
A0A0S4JE69 | Bodo saltans | 38% | 98% |
A0A1X0NWJ3 | Trypanosomatidae | 41% | 98% |
A0A3S5H780 | Leishmania donovani | 82% | 100% |
A0A422MW34 | Trypanosoma rangeli | 37% | 99% |
A4HYK8 | Leishmania infantum | 82% | 100% |
C9ZHV7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 98% |
E9AUF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4QD27 | Leishmania major | 81% | 100% |
V5BQX0 | Trypanosoma cruzi | 38% | 88% |